HAVEN 2 Updated Analysis: Multicenter, Open-Label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Pediatric Patients with Hemophilia A with Inhibitors

被引：0
|
作者：
Young, Guy
Sidonio, Robert F.
Liesner, Ri
Oldenburg, Johannes
Chang, Tiffany
Uguen, Marianne
Dhalluin, Christophe
Schmitt, Christophe
Levy, Gallia G.
Shima, Midori
Mahlangu, Johnny
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
85
引用
收藏
页数：4
相关论文
共 50 条
  • [21] A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results
    Magnolo, Nina
    Kingo, Kulli
    Laquer, Vivian
    Browning, John
    Reich, Adam
    Szepietowski, Jacek C.
    Keefe, Deborah
    Mazur, Rafal
    Ghelani, Prayashi
    Forrer, Pascal
    Wraith, LindaAnn
    Patekar, Manmath
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (01) : 122 - 130
  • [22] Factor VIII Use in the Treatment of Breakthrough Bleeds in Hemophilia A Patients without Inhibitors on Emicizumab Prophylaxis: The Phase 3 HAVEN 3 Study Experience
    Callaghan, Michael
    Trzaskoma, Benjamin
    Ko, Richard H.
    Lee, Lucy
    Patel, Anisha M.
    Tzeng, Eunice
    Shah, Michelle Lynn
    Chang, Tiffany Y.
    Niggli, Markus
    Dhalluin, Christophe
    Mahlangu, Johnny
    BLOOD, 2019, 134
  • [23] Every 2 Weeks or Every 4 Weeks Subcutaneous Injection of Emicizumab in Pediatric Patients with Severe Hemophilia a without Inhibitors: A Multi-Center, Open-Label Study in Japan (HOHOEMI Study)
    Shima, Midori
    Nogami, Keiji
    Nagami, Sayaka
    Yoshida, Seitaro
    Yoneyama, Koichiro
    Ishiguro, Akira
    Suzuki, Takashi
    Taki, Masashi
    BLOOD, 2018, 132
  • [24] A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)
    Zhang, Fengkui
    Peng, Guangxin
    He, Guangsheng
    Chang, Hong
    Gao, Sujun
    Liu, Xinjian
    Chen, Tong
    Li, Pei
    Han, Bing
    Miao, Miao
    Ge, Zheng
    Ge, Xiaoyan
    Li, Fei
    Li, Yingmei
    Wang, Shunqing
    Wang, Yi
    Shen, Yaqi
    Tai, Yanfei
    Zhang, Tao
    Zhu, Bo
    Zou, Jianjun
    BLOOD, 2020, 136
  • [25] A Randomized, Open-Label, Multicenter, Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of KRT-232 Compared with Ruxolitinib in Patients with Phlebotomy-Dependent Polycythemia Vera
    Gotlib, Jason
    Gabrail, Nashat
    O'Connell, Casey L.
    Garcia-Delgado, Regina
    Sbardellati, Timothy
    Rothbaum, Wayne M.
    McGreivy, Jesse
    Harrison, Claire N.
    Kiladjian, Jean-Jacques
    BLOOD, 2019, 134
  • [26] A randomized, multicenter, open-label study to evaluate the safety and efficacy of infliximab in pediatric patients with moderate-to-severe Crohn's disease
    不详
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 41 (04): : 539 - 539
  • [27] Safety and Pharmacokinetics of IGSC 20% in Subjects with Primary Immunodeficiency in an Open-label, Multicenter, Phase 3 Study
    Sleasman, John
    Darter, Amy
    Lumry, William
    Hussain, Iftikhar
    Wedner, H. James
    Harris, James, III
    Courtney, Kecia
    Mondou, Elsa
    Lin, Jiang
    Stein, Mark R.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2019, 39 : S48 - S49
  • [28] Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors
    Shima, Midori
    Hanabusa, Hideji
    Taki, Masashi
    Matsushita, Tadashi
    Sato, Tetsuji
    Fukutake, Katsuyuki
    Kasai, Ryu
    Yoneyama, Koichiro
    Yoshida, Hiroki
    Nogami, Keiji
    BLOOD ADVANCES, 2017, 1 (22) : 1891 - 1899
  • [29] Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 study
    Ishida, Hideki
    Goto, Norihiko
    Imamura, Ryoichi
    Sasaki, Hajime
    Unagami, Kohei
    Futamura, Kenta
    Murata, Yoshihiko
    Oshima, Nobuyuki
    Eto, Toshiko
    Haber, Barbara
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (08) : 822 - 831
  • [30] Study Design of an Open-Label, SingleArm, Multicenter, Phase 2 Study to Evaluate the Safety and Efficacy of Defibrotide in Adult Patients with Transplant-Associated Thrombotic Microangiopathy
    Ho, Vincent T.
    Keshelava, Nino
    Swann, Suzanne
    Tappe, William
    BLOOD, 2019, 134
12345